 | • レポートコード：D005-11929 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、小児用薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。小児用薬の種類別市場規模（アレルギー・呼吸器治療薬、抗感染症薬、がん治療薬、心血管治療薬、中枢神経系薬、消化器薬、ホルモン薬、泌尿器薬）、用途別市場規模（病院、クリニック、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Genentech、Bristol-Myers Squibb、Bayer、Forest Laboratories、Boehringer Ingelheim、Johnson & Johnson、Eli Lilly、Colgate Oral Pharmaceuticals、GlaxoSmithKline、Pfizer、Schering-Plough、MedImmune、Pharmacia、Novo Nordisk、Merck、Roche、Novartis Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・小児用薬の北米市場（アメリカ、カナダ、メキシコ） ・小児用薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・小児用薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・小児用薬の南米市場（ブラジル、アルゼンチン） ・小児用薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アレルギー・呼吸器治療薬、抗感染症薬、がん治療薬、心血管治療薬、中枢神経系薬、消化器薬、ホルモン薬、泌尿器薬 ・用途別分析：病院、クリニック、ドラッグストア ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Pediatric Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pediatric Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pediatric Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pediatric Drugs market has been segmented into
Allergy and Respiratory Drugs
Anti-Infectives
Cancer Therapies
Cardiovascular Drugs
Central Nervous System Drugs
Gastrointestinal Drugs
Hormone Drugs
Urological Drugs
By Application, Pediatric Drugs has been segmented into:
Hospital
Clinic
Drugstore
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pediatric Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Pediatric Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pediatric Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Pediatric Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Pediatric Drugs Market Share Analysis
Pediatric Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pediatric Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pediatric Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Pediatric Drugs are:
Abbott Laboratories
Genentech
Bristol-Myers Squibb
Bayer
Forest Laboratories
Boehringer Ingelheim
Johnson & Johnson
Eli Lilly
Colgate Oral Pharmaceuticals
GlaxoSmithKline
Pfizer
Schering-Plough
MedImmune
Pharmacia
Novo Nordisk
Merck
Roche
Novartis Pharmaceuticals
Among other players domestic and global, Pediatric Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pediatric Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pediatric Drugs, with price, sales, revenue and global market share of Pediatric Drugs in 2018 and 2019.
Chapter 3, the Pediatric Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pediatric Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pediatric Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pediatric Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pediatric Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pediatric Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Allergy and Respiratory Drugs
1.2.3 Anti-Infectives
1.2.4 Cancer Therapies
1.2.5 Cardiovascular Drugs
1.2.6 Central Nervous System Drugs
1.2.7 Gastrointestinal Drugs
1.2.8 Hormone Drugs
1.2.9 Urological Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Pediatric Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Overview of Global Pediatric Drugs Market
1.4.1 Global Pediatric Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genentech
2.2.1 Genentech Details
2.2.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genentech SWOT Analysis
2.2.4 Genentech Product and Services
2.2.5 Genentech Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Forest Laboratories
2.5.1 Forest Laboratories Details
2.5.2 Forest Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Forest Laboratories SWOT Analysis
2.5.4 Forest Laboratories Product and Services
2.5.5 Forest Laboratories Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Colgate Oral Pharmaceuticals
2.9.1 Colgate Oral Pharmaceuticals Details
2.9.2 Colgate Oral Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Colgate Oral Pharmaceuticals SWOT Analysis
2.9.4 Colgate Oral Pharmaceuticals Product and Services
2.9.5 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline SWOT Analysis
2.10.4 GlaxoSmithKline Product and Services
2.10.5 GlaxoSmithKline Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pfizer SWOT Analysis
2.11.4 Pfizer Product and Services
2.11.5 Pfizer Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Schering-Plough
2.12.1 Schering-Plough Details
2.12.2 Schering-Plough Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Schering-Plough SWOT Analysis
2.12.4 Schering-Plough Product and Services
2.12.5 Schering-Plough Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 MedImmune
2.13.1 MedImmune Details
2.13.2 MedImmune Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 MedImmune SWOT Analysis
2.13.4 MedImmune Product and Services
2.13.5 MedImmune Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Pharmacia
2.14.1 Pharmacia Details
2.14.2 Pharmacia Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Pharmacia SWOT Analysis
2.14.4 Pharmacia Product and Services
2.14.5 Pharmacia Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novo Nordisk
2.15.1 Novo Nordisk Details
2.15.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novo Nordisk SWOT Analysis
2.15.4 Novo Nordisk Product and Services
2.15.5 Novo Nordisk Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Merck
2.16.1 Merck Details
2.16.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Merck SWOT Analysis
2.16.4 Merck Product and Services
2.16.5 Merck Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Roche
2.17.1 Roche Details
2.17.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Roche SWOT Analysis
2.17.4 Roche Product and Services
2.17.5 Roche Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Novartis Pharmaceuticals
2.18.1 Novartis Pharmaceuticals Details
2.18.2 Novartis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Novartis Pharmaceuticals SWOT Analysis
2.18.4 Novartis Pharmaceuticals Product and Services
2.18.5 Novartis Pharmaceuticals Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pediatric Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pediatric Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pediatric Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Pediatric Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pediatric Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Pediatric Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pediatric Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Pediatric Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Pediatric Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pediatric Drugs Sales and Growth Rate (2015-2020)
4.5 South America Pediatric Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pediatric Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pediatric Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Pediatric Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Pediatric Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Pediatric Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Pediatric Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Pediatric Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pediatric Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Pediatric Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pediatric Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Pediatric Drugs Sales and Growth Rate (2015-2020)
6.3 UK Pediatric Drugs Sales and Growth Rate (2015-2020)
6.4 France Pediatric Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Pediatric Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Pediatric Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pediatric Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pediatric Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pediatric Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Pediatric Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Pediatric Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Pediatric Drugs Sales and Growth Rate (2015-2020)
7.5 India Pediatric Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pediatric Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Pediatric Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pediatric Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Pediatric Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Pediatric Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pediatric Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Pediatric Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pediatric Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pediatric Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pediatric Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pediatric Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Pediatric Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Pediatric Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Pediatric Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pediatric Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Pediatric Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Pediatric Drugs Price by Type (2015-2020)
11 Global Pediatric Drugs Market Segment by Application
11.1 Global Pediatric Drugs Sales Market Share by Application (2015-2020)
11.2 Global Pediatric Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Pediatric Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pediatric Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Pediatric Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Pediatric Drugs Market Forecast (2021-2025)
12.2.2 Europe Pediatric Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pediatric Drugs Market Forecast (2021-2025)
12.2.4 South America Pediatric Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pediatric Drugs Market Forecast (2021-2025)
12.3 Pediatric Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Pediatric Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Pediatric Drugs Market Share Forecast by Type (2021-2025)
12.4 Pediatric Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Pediatric Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Pediatric Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Pediatric Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pediatric Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pediatric Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Pediatric Drugs Major Business
Table 9. Abbott Laboratories Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Abbott Laboratories SWOT Analysis
Table 11. Abbott Laboratories Pediatric Drugs Product and Services
Table 12. Abbott Laboratories Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Genentech Basic Information, Manufacturing Base and Competitors
Table 14. Genentech Pediatric Drugs Major Business
Table 15. Genentech Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Genentech SWOT Analysis
Table 17. Genentech Pediatric Drugs Product and Services
Table 18. Genentech Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Pediatric Drugs Major Business
Table 21. Bristol-Myers Squibb Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Bristol-Myers Squibb SWOT Analysis
Table 23. Bristol-Myers Squibb Pediatric Drugs Product and Services
Table 24. Bristol-Myers Squibb Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bayer Basic Information, Manufacturing Base and Competitors
Table 26. Bayer Pediatric Drugs Major Business
Table 27. Bayer Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Bayer SWOT Analysis
Table 29. Bayer Pediatric Drugs Product and Services
Table 30. Bayer Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Forest Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Forest Laboratories Pediatric Drugs Major Business
Table 33. Forest Laboratories Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Forest Laboratories SWOT Analysis
Table 35. Forest Laboratories Pediatric Drugs Product and Services
Table 36. Forest Laboratories Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 38. Boehringer Ingelheim Pediatric Drugs Major Business
Table 39. Boehringer Ingelheim Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Boehringer Ingelheim SWOT Analysis
Table 41. Boehringer Ingelheim Pediatric Drugs Product and Services
Table 42. Boehringer Ingelheim Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Pediatric Drugs Major Business
Table 45. Johnson & Johnson Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Johnson & Johnson SWOT Analysis
Table 47. Johnson & Johnson Pediatric Drugs Product and Services
Table 48. Johnson & Johnson Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly Pediatric Drugs Major Business
Table 51. Eli Lilly Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Eli Lilly SWOT Analysis
Table 53. Eli Lilly Pediatric Drugs Product and Services
Table 54. Eli Lilly Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Colgate Oral Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Colgate Oral Pharmaceuticals Pediatric Drugs Major Business
Table 57. Colgate Oral Pharmaceuticals Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Colgate Oral Pharmaceuticals SWOT Analysis
Table 59. Colgate Oral Pharmaceuticals Pediatric Drugs Product and Services
Table 60. Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline Pediatric Drugs Major Business
Table 63. GlaxoSmithKline Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 64. GlaxoSmithKline SWOT Analysis
Table 65. GlaxoSmithKline Pediatric Drugs Product and Services
Table 66. GlaxoSmithKline Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Pediatric Drugs Major Business
Table 69. Pfizer Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Pfizer SWOT Analysis
Table 71. Pfizer Pediatric Drugs Product and Services
Table 72. Pfizer Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Schering-Plough Basic Information, Manufacturing Base and Competitors
Table 74. Schering-Plough Pediatric Drugs Major Business
Table 75. Schering-Plough Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Schering-Plough SWOT Analysis
Table 77. Schering-Plough Pediatric Drugs Product and Services
Table 78. Schering-Plough Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. MedImmune Basic Information, Manufacturing Base and Competitors
Table 80. MedImmune Pediatric Drugs Major Business
Table 81. MedImmune Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 82. MedImmune SWOT Analysis
Table 83. MedImmune Pediatric Drugs Product and Services
Table 84. MedImmune Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Pharmacia Basic Information, Manufacturing Base and Competitors
Table 86. Pharmacia Pediatric Drugs Major Business
Table 87. Pharmacia Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Pharmacia SWOT Analysis
Table 89. Pharmacia Pediatric Drugs Product and Services
Table 90. Pharmacia Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 92. Novo Nordisk Pediatric Drugs Major Business
Table 93. Novo Nordisk Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Novo Nordisk SWOT Analysis
Table 95. Novo Nordisk Pediatric Drugs Product and Services
Table 96. Novo Nordisk Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Pediatric Drugs Major Business
Table 99. Merck Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 100. Merck SWOT Analysis
Table 101. Merck Pediatric Drugs Product and Services
Table 102. Merck Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Roche Basic Information, Manufacturing Base and Competitors
Table 104. Roche Pediatric Drugs Major Business
Table 105. Roche Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 106. Roche SWOT Analysis
Table 107. Roche Pediatric Drugs Product and Services
Table 108. Roche Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Novartis Pharmaceuticals Pediatric Drugs Type and Application
Table 110. Novartis Pharmaceuticals Pediatric Drugs Major Business
Table 111. Novartis Pharmaceuticals Pediatric Drugs Total Revenue (USD Million) (2017-2018)
Table 112. Novartis Pharmaceuticals SWOT Analysis
Table 113. Novartis Pharmaceuticals Pediatric Drugs Product and Services
Table 114. Novartis Pharmaceuticals Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Pediatric Drugs Sales by Manufacturer (2018-2019) (MT)
Table 116. Global Pediatric Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Pediatric Drugs Sales by Regions (2015-2020) (MT)
Table 118. Global Pediatric Drugs Sales Market Share by Regions (2015-2020)
Table 119. Global Pediatric Drugs Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Pediatric Drugs Sales by Countries (2015-2020) (MT)
Table 121. North America Pediatric Drugs Sales Market Share by Countries (2015-2020)
Table 122. North America Pediatric Drugs Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Pediatric Drugs Revenue Market Share by Countries (2015-2020)
Table 124. Europe Pediatric Drugs Sales by Countries (2015-2020) (MT)
Table 125. Europe Pediatric Drugs Sales Market Share by Countries (2015-2020)
Table 126. Europe Pediatric Drugs Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Pediatric Drugs Sales by Regions (2015-2020) (MT)
Table 128. Asia-Pacific Pediatric Drugs Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Pediatric Drugs Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Pediatric Drugs Sales by Countries (2015-2020) (MT)
Table 131. South America Pediatric Drugs Sales Market Share by Countries (2015-2020)
Table 132. South America Pediatric Drugs Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Pediatric Drugs Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Pediatric Drugs Sales by Countries (2015-2020) (MT)
Table 135. Middle East & Africa Pediatric Drugs Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Pediatric Drugs Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Pediatric Drugs Revenue Market Share by Countries (2015-2020)
Table 138. Global Pediatric Drugs Sales by Type (2015-2020) (MT)
Table 139. Global Pediatric Drugs Sales Share by Type (2015-2020)
Table 140. Global Pediatric Drugs Revenue by Type (2015-2020) (USD Million)
Table 141. Global Pediatric Drugs Revenue Share by Type (2015-2020)
Table 142. Global Pediatric Drugs Sales by Application (2015-2020) (MT)
Table 143. Global Pediatric Drugs Sales Share by Application (2015-2020)
Table 144. Global Pediatric Drugs Sales Forecast by Regions (2021-2025) (MT)
Table 145. Global Pediatric Drugs Market Share Forecast by Regions (2021-2025)
Table 146. Global Pediatric Drugs Sales Forecast by Type (2021-2025) (MT)
Table 147. Global Pediatric Drugs Market Share Forecast by Type (2021-2025)
Table 148. Global Pediatric Drugs Sales Forecast by Application (2021-2025)
Table 149. Global Pediatric Drugs Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pediatric Drugs Picture
Figure 2. Global Sales Market Share of Pediatric Drugs by Type in 2019
Figure 3. Allergy and Respiratory Drugs Picture
Figure 4. Anti-Infectives Picture
Figure 5. Cancer Therapies Picture
Figure 6. Cardiovascular Drugs Picture
Figure 7. Central Nervous System Drugs Picture
Figure 8. Gastrointestinal Drugs Picture
Figure 9. Hormone Drugs Picture
Figure 10. Urological Drugs Picture
Figure 11. Pediatric Drugs Sales Market Share by Application in 2018
Figure 12. Hospital Picture
Figure 13. Clinic Picture
Figure 14. Drugstore Picture
Figure 15. Global Pediatric Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Pediatric Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Pediatric Drugs Sales Market Share by Manufacturer in 2019
Figure 36. Global Pediatric Drugs Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Pediatric Drugs Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Pediatric Drugs Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 41. Global Pediatric Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Pediatric Drugs Revenue Market Share by Regions (2015-2020)
Figure 43. Global Pediatric Drugs Revenue Market Share by Regions in 2018
Figure 44. North America Pediatric Drugs Sales and Growth Rate (2015-2020)
Figure 45. Europe Pediatric Drugs Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Pediatric Drugs Sales and Growth Rate (2015-2020)
Figure 47. South America Pediatric Drugs Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Pediatric Drugs Sales and Growth Rate (2015-2020)
Figure 49. North America Pediatric Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Pediatric Drugs Sales Market Share by Countries (2015-2020)
Figure 51. North America Pediatric Drugs Sales Market Share by Countries in 2018
Figure 52. North America Pediatric Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Pediatric Drugs Revenue Market Share by Countries in 2018
Figure 54. United States Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 55. Canada Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 56. Mexico Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 57. Europe Pediatric Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Pediatric Drugs Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Pediatric Drugs Revenue Market Share by Countries in 2019
Figure 60. Germany Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 61. UK Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 62. France Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 63. Russia Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 64. Italy Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 65. Asia-Pacific Pediatric Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Pediatric Drugs Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Pediatric Drugs Revenue Market Share by Regions 2019
Figure 68. China Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 69. Japan Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 70. Korea Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 71. India Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 72. Southeast Asia Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 73. South America Pediatric Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Pediatric Drugs Sales Market Share by Countries in 2019
Figure 75. South America Pediatric Drugs Revenue Market Share by Countries in 2019
Figure 76. Brazil Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 77. Argentina Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 78. Middle East and Africa Pediatric Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Pediatric Drugs Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Pediatric Drugs Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Pediatric Drugs Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 83. Egypt Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 84. Turkey Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 85. South Africa Pediatric Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 86. Global Pediatric Drugs Sales and Growth Rate (2021-2025) (MT)
Figure 87. Global Pediatric Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Pediatric Drugs Market Forecast (2021-2025) (MT)
Figure 89. Europe Sales Pediatric Drugs Market Forecast (2021-2025) (MT)
Figure 90. Asia-Pacific Sales Pediatric Drugs Market Forecast (2021-2025) (MT)
Figure 91. South America Sales Pediatric Drugs Market Forecast (2021-2025) (MT)
Figure 92. Middle East & Africa Sales Pediatric Drugs Market Forecast (2021-2025) (MT)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…- 自殺防止薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Suicide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 3696 million by 2025, from USD 3384.6 million in 2019. The Anti-Suicide Drugs …
- 子宮頸がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cervical Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14770 million by 2025, from USD 13550 million in 2019. The Cervical Cancer …
- 非ステロイド性抗炎症薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nonsteroidal Antiinflammatory Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nonsteroi…
- 精神疾患治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Mental Illness Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mental Illness Drugs mar…